Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Maxacalcitol

    ACTIVE PHARMA INGREDIENTS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Chugai gets favorable final ruling on Oxarol patent dispute
    Chugai gets favorable final ruling on Oxarol patent dispute

    27 Mar 2017

    // THE PHARMALETTER

    https://www.thepharmaletter.com/article/chugai-gets-favorable-final-ruling-on-oxarol-patent-dispute

    THE PHARMALETTER
    27 Mar 2017
    Share Share
    Chugai, Maruho introduce Marduox Ointment for psoriasis vulgaris
    Chugai, Maruho introduce Marduox Ointment for psoriasis vulgaris

    22 Jun 2016

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=95849&sid=2

    PHARMABIZ
    22 Jun 2016
    Share Share
    Chugai Wins the First Instance of the Patent Infringement Lawsuit for Oxarol® Ointment
    Chugai Wins the First Instance of the Patent Infringement Lawsuit for Oxarol® Ointment

    25 Dec 2014

    // PRESS RELEASE

    https://www.chugai-pharm.co.jp/news/cont_file_dl.php?f=141225eOxa.pdf&src=[%0],[%1]&rep=130,217

    PRESS RELEASE
    25 Dec 2014
    Share Share